Hu Zeng

26PUBLICATIONS

55CO-AUTHORS

GlycobiologyHaematological tumoursAutoimmunityMolecular targetsMedical biochemistry - amino acids and metabolites

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|Jun 05, 2026

ACLY integrates metabolism and chromatin accessibility to enable B Cell activation and humoral immunity.

|Jun 01, 2026

The Association of Osteoarthritis With De Novo Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study.

|Apr 01, 2026

Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies.

Xingxing Zhu, Yue Yu, Shiju Chen

|Feb 06, 2026

The association of osteoarthritis with the risk of de novo inflammatory arthritis in patients receiving immune checkpoint inhibitors: a retrospective study.

Shiju Chen, Xingxing Zhu, Zhiqiang Zhang

|Jun 12, 2025

Inflammatory arthritis immune related adverse events represent a unique autoimmune disease entity primarily driven by T cells, but likely not autoantibodies.

Xingxing Zhu, Yue Yu, Yanfeng Li

|Dec 10, 2024

Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in systemic lupus erythematosus.

Minji Ai, Xian Zhou, Michele Carrer

Pageof 5

Frequent Collaborators

Xingxing Zhu

Geoffrey Neale

Hongbo Chi

Haidong Dong

Taro Hitosugi

Aaron S Mansfield

Yue Wu

Peter Vogel

Joanina K Gicobi

Whitney Barham

Frequent Collaborators

Xingxing Zhu

Geoffrey Neale

Hongbo Chi

Haidong Dong